Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples